AIMTOR, a BRET Biosensor for Live Recording of mTOR Activity in Cell Populations and Single Cells

Archive ouverte

Bouquier, Nathalie | Moutin, Enora | Perroy, Julie | Ollendorff, Vincent

Edité par CCSD ; Bio-protocol LCC -

International audience. Mammalian target of rapamycin (mTOR) controls many crucial cellular functions, including protein synthesis, cell size, energy metabolism, lysosome and mitochondria biogenesis, and autophagy. Consequently, deregulation of mTOR signaling plays a role in numerous pathological conditions such as cancer, metabolic disorders and neurological diseases. Developing new tools to monitor mTOR spatiotemporal activation is crucial to better understand its roles in physiological and pathological conditions. However, the most widely used method to report mTOR activity relies on the quantification of specific mTOR-phosphorylated substrates by western blot. This approach requires cellular lysate preparation, which restricts the quantification to a single time point. Here, we present a simple protocol to study mTOR activity in living cells in real time using AIMTOR, an intramolecular BRET-based (bioluminescence resonance energy transfer) biosensor that we recently designed (Bouquier et al., 2020). We describe transfection of AIMTOR in the C2C12 cell line and procedures to monitor BRET in a cell population using a plate reader and in single cells by microscopy. Importantly, this protocol is transposable to any cell line and primary cells. In addition, several subcellular compartment-specific versions of AIMTOR have been developed, enabling compartmentalized assessment of mTOR activity. This protocol describes how to use the sensitive AIMTOR biosensor to investigate mTOR signaling dynamics in living cells.

Consulter en ligne

Suggestions

Du même auteur

AIMTOR, a BRET biosensor for live imaging, reveals subcellular mTOR signaling and dysfunctions

Archive ouverte | Bouquier, Nathalie | CCSD

International audience. Background: mTOR signaling is an essential nutrient and energetic sensing pathway. Here we describe AIMTOR, a sensitive genetically encoded BRET (Bioluminescent Resonance Energy Transfer) bio...

D1-mGlu5 heteromers mediate noncanonical dopamine signaling in Parkinson’s disease

Archive ouverte | Sebastianutto, Irene | CCSD

International audience. Dopamine receptor D1 modulates glutamatergic transmission in cortico-basal ganglia circuits and represents a major target of L-DOPA therapy in Parkinson's disease. Here we show that D1 and me...

Restoring glutamate receptosome dynamics at synapses rescues autism-like deficits in Shank3-deficient mice

Archive ouverte | Moutin, Enora | CCSD

International audience. Shank3 monogenic mutations lead to autism spectrum disorders (ASD). Shank3 is part of the glutamate receptosome that physically links ionotropic NMDA receptors to metabotropic mGlu5 receptors...

Chargement des enrichissements...